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INTRODUCTION
Reverse transcriptase polymerase chain reaction (RT-PCR)
is used to confirm true hepatitis C virus (HCV) infection in
clinical practice (1). The HCV genotype is useful for identi-
fying the transmission of HCV (2, 3) and for understanding
the natural history of HCV infection (4). Several studies have
reported that the distribution of the HCV genotype differs
between countries; moreover, response to interferon therapy
depends upon HCV genotype (5, 6). It would be helpful for
physicians in their decision-making process to have knowl-
edge about the distribution of HCV genotype and the geno-
typic factors associated with HCV infection. In addition, it
has been suggested that the distribution of HCV genotype
in Koreans differs substantially from those of the Japanese
and western people (7). Therefore, we undertook this study
to identify the HCV genotype profile and possible risk fac-
tors by genotype in Korean patients. 
MATERIALS AND METHODS
Case selection
The subjects were anti-HCV ELISA-positive cases who had
undergone a periodic health examination between September
1994 and December 1998 at the Asan Medical Center in
Seoul, Korea. This Medical Center is a private university-
based tertiary medical institution primarily serving residents
of Seoul. By November of 1999, 390 (57.4%) of 680 subjects,
mailed an invitation to participate in the study, had volun-
teered to take part. Using a structured questionnaire, parti-
cipants were asked about their past medical history including
surgical and dental procedures, blood transfusions, needle
sharing, jaundice, acupuncture, endoscopy, tattoos, and ear
piercing. Testing included alanine aminotransferase (ALT)
measurement and an abdominal sonogram, and RT-PCR was
performed to confirm the status of HCV infection. Of the
390 patients, 242 (62.1%) were found to be infected with
HCV by RT-PCR (PCR-positive). The HCV genotype was
identified in 178 (73.6%) out of 242 patients, who tested
positive for RT-PCR by repeated examination at the Liver
Research Institute, Seoul National University. All 178 cases
were evaluated for liver disease by ALT and received an ultra-
sound examination; 83 had elevated ALT, 18 cirrhosis, and
in 77 the liver function was normal.
Control selection
The spouses of 242 PCR-positive patients were invited by
letter to participate as controls. Of these, 130 responded and
tested for anti-HCV antibody. 125 spouses negative for anti-
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Risk Factors for Hepatitis C Virus Infection Among Koreans 
According to the Hepatitis C Virus Genotype
To investigate risk factors for HCV infection according to the genotype, we stud-
ied 178 patients positive for HCV-PCR and 226 controls that were negative for
the anti-HCV antibody. One hundred and twenty five controls (community con-
trol) were recruited from spouses of HCV-PCR-positive patients and the other
101 from hospital visitors (hospital control). HCV genotyping was performed by
PCR, and epidemiological data were obtained from all participants. The distribu-
tion of HCV genotypes was as follows - 1a (0.6%), 1b (39.9%), 2a (38.2%), 2b
(0%), 3 (1.1%), and unclassified (20.2%). By multivariate analysis, blood transfu-
sion (OR 2.90) and endoscopy (OR 2.80) were found to be risk factors for HCV
genotype 1b versus the community control. Similarly, blood transfusion (OR 3.17)
was found to be risk factors for HCV genotype 1b versus the hospital control.
Blood transfusion (OR 2.75) and endoscopy (OR 3.57) were risk factors for HCV
genotype 2a versus the community control, and blood transfusion (OR 4.55) and
endoscopy (OR 2.16) were those versus the hospital control. Our results suggest
that the risk factors for HCV infection are similar among the different genotypes.
Blood transfusion and endoscopy were found to be associated with HCV infection. 
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Fig. 1. Schematic presentation of cases and controls selection.
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HCV ELISA were enrolled as community controls. The pro-
portion of women in the community controls was higher than
that of the cases (Table 1).
All 104 subjects who underwent a periodic health exami-
nation during the same period and revisited Asan Medical
Center were tested for anti-HCV ELISA. Of the 104 subjects,
101 who were negative for anti-HCV ELISA were enrolled
as hospital controls (Fig. 1). A higher number of women and
younger subjects were enrolled in the hospital controls than
those in the cases (Table 1). All control subjects were inter-
viewed using the same questionnaire. 
Laboratory tests
All the participants were screened with a third generation
anti-HCV ELISA (Abbott Laboratories). Those who tested
positive for anti-HCV antibody and RT-PCR were defined as
HCV infection and those who showed elevated ALT levels ex-
ceeding the upper limit of normal for our laboratories (ALT>
40 IU/L) as elevated ALT. To detect hepatitis C viral sequences,
serum RNA was extracted, reverse transcribed, and ampli-
fied by nested PCR (1) at the Liver Research Institute, Seoul
National University. We were able to determine five genotypes
of HCV, 1a, 1b, 2a, 2b and 3, using this method (Table 2).
Statistical analysis
The association between possible risk factors with HCV
infection for the PCR-positive cases and controls was assessed
using odds ratios. The  2 test and Fisher's exact test were
used as appropriate to determine whether the associations
were statistically significant. Factors that were significant by
univariate analyses (p<0.05) were examined after stratifying
by possible confounders using the Mantel Haenszel method.
Multiple logistic regression analysis was used to determine
whether the observed associations were independent of other
risk factors. 
RESULTS
Distribution of HCV genotypes
Of the 178 HCV RNA-positive subjects, genotyping re-
sults were obtained in 142. The distribution of HCV geno-
types is detailed in Table 2. The most common genotypes
were type 1b (39.9%) and type 2a (38.2%), while type 3
(1.1%) and type 1a (0.6%) were less common. None of the
patients studied had genotype 2b. In 77 carriers of HCVGenotypic Risk Factors of HCV Infection 189
RNA, genotype 2a was most common (40.3%), followed
by genotype 1b (33.8%) and genotype 3 (1.3%). In 83 cases
of chronic hepatitis, genotype 1b was most common (50.6%),
followed by genotype 2a (32.5%) and genotype 1a and 3
(1.2%). In 18 patients with liver cirrhosis, genotype 2a was
most common (55.6%), followed by genotype 1b (16.7%).
Risk factors for HCV genotype 1b
By univariate analysis, blood transfusion and endoscopy
were associated with the risk of the HCV genotype 1b ver-
sus the community controls, and surgical procedure, blood
transfusion, endoscopy and needle sharing were associated
with the risk of HCV genotype 1b versus the hospital con-
trols (Table 3). Other possible risk factors, such as a history
#, Alanine aminotransferase.
Diagnosis Normal ALT
# 77 43.3
Elevated ALT 83 46.6
Cirrhosis 18 10.1
Genotype 1a 1 0.6
1b 71 39.9
2a 68 38.2
2b 0 0.0
3 2 1.1
unclassified 36 20.2
Total 178 100.0
No. %
PCR-positive cases
Table 2. Clinical diagnoses and genotypes of 178 hepatitis C
virus PCR-positive patients
#, million Korean won; *, p<0.01 versus community and hospital controls by
2 test; 
� , p<0.01 versus hospital controls by Mantel-Haenszel test of trend.
Gender
Male 100 56.2* 42 33.6 39 38.6
Female 78 43.8 83 66.4 62 61.4
Age (yr)
<50 50 28.1
� 44 35.2 45 44.6
50-59 53 29.8 39 31.2 31 30.7
≥60 75 42.1 42 33.6 25 24.8
Years of education
<12 46 26.4 30 24.4 17 17.0
12 51 29.3 46 37.4 45 45.0
>12 77 44.3 47 38.2 38 38.0
Income / Month
<1 million
# 33 19.2 20 16.7 15 16.0
1-3 104 60.5 75 62.5 54 57.4
>3 35 20.3 25 20.8 25 26.6
Smoking
current smoker 32 18.4 18 14.6 21 21.4
non-smoker 142 81.6 105 85.4 77 78.6
Alcohol
drinker 58 33.5 35 28.5 44 44.9
non-drinker 115 66.5 88 71.5 54 55.1
Total 178 100.0 125 100.0 101 100.0
No. % No. % No. %
PCR-positive 
cases Characteristics
Community 
controls
Hospital 
controls 
Table 1. Demographic characteristics of 404 study subjects
#, Sexually transmitted disease; *, Mantel-Haenszel estimates adjusted for age and sex. OR: Odds ratio.
Surgical procedure Yes 43 60.6 62 50.8 1.57 (0.84-2.95) 37 37.0 2.67 (1.36-5.24)
No 28 39.4 60 49.2 63 63.0
Blood transfusion Yes 32 45.7 23 19.8 3.35 (1.72-6.51) 16 16.5 4.85 (2.26-10.42)
No 38 54.3 93 80.2 81 83.5
Needle sharing Yes 4 5.8 2 1.8 4.05 (0.87-18.86) 1 98.9 11.38 (1.44-89.97)
No 65 94.2 110 98.2 88 1.1
Endoscopy Yes 49 70.0 56 46.3 2.87 (1.47-5.60) 61 60.4 1.62 (0.80-3.28)
No 21 30.0 65 53.7 40 39.6
Dental procedure Yes 46 67.6 78 67.2 0.86 (0.43-1.74) 65 68.4 0.90 (0.44-1.83)
No 22 32.4 38 32.8 30 31.6
Acupuncture Yes 58 81.7 95 78.5 1.03 (0.47-2.78) 74 77.1 1.10 (0.49-2.47)
No 13 18.3 26 21.5 22 22.9
Tattooing Yes 13 18.8 20 16.9 1.67 (0.72-3.92) 28 29.2 0.88 (0.36-2.12)
No 56 81.2 98 83.1 68 70.8
Ear piercing Yes 17 24.3 38 31.9 1.61 (0.66-3.93) 38 39.2 0.94 (0.37-2.42)
No 53 75.7 81 68.1 59 60.8
History of STD
# Yes 18 26.5 22 18.6 1.22 (0.56-2.66) 13 13.5 1.69 (0.72-3.94)
No 50 73.5 96 81.4 83 86.5
Family history of hepatitis Yes 19 28.8 59 51.8 0.42 (0.21-0.84) 24 25.8 1.20 (0.57-2.54)
No 47 71.2 55 48.2 69 74.2
Total 71 100.0 125 100.0 101 100.0
No. % No. % No. %
Genotype 1b cases Community controls
OR* (95% CI)
Hospital controls
OR* (95% CI) Characteristics
Table 3. Univariate analysis of potential risk factors for hepatitis C virus genotype 1b190 Y.S. Kim, Y.-O. Ahn, H.S. Lee
of dental procedure, acupuncture, tattooing, ear piercing,
sexually transmitted disease and family history of hepatitis
were not associated with an increased risk of HCV genotype
1b (Table 3). 
By multivariate analysis, the risk factors for HCV genotype
1b were age higher than 10 yr (OR 1.75, 95%CI 1.12-2.74),
blood transfusion (OR 2.90, 95%CI 1.24-6.77) and endos-
copy (OR 2.80, 95%CI 1.34-5.84) versus the community
controls, and age higher than 10 yr (OR 2.10, 95%CI 1.34-
3.30) and blood transfusion (OR 3.17, 95%CI 1.29-7.83)
versus the hospital controls (Table 4).
Risk factors for HCV genotype 2a
Blood transfusion and endoscopy were associated with the
risk of HCV genotype 2a versus the community controls, and
blood transfusion was associated with the risk of HCV geno-
type 2a versus the hospital controls (Table 5). Other possible
risk factors, such as a surgical procedure, needle sharing, his-
tory of dental procedure, acupuncture, tattooing, ear piercing,
sexually transmitted disease and family history of hepatitis
were not associated with an increased risk of HCV genotype
2a (Table 5). 
By multivariate analysis, the risk factors for HCV genotype
2a were blood transfusion (OR 2.75, 95%CI 1.28-5.91) and
endoscopy (OR 3.57, 95%CI 1.69-7.55) versus the commu-
nity controls, and blood transfusion (OR 4.55, 95%CI 2.00-
10.38) and endoscopy (OR 2.16, 95%CI 1.00-4.66) versus
the hospital controls (Table 6). 
DISCUSSION
This study shows that the most frequent genotypes among
Female 0.39 0.19-0.81 0.37 0.17-0.80
Age (10 yr) 1.75 1.12-2.74 2.10 1.34-3.30
Surgical procedure 0.86 0.39-1.90 1.63 0.74-3.60
Blood transfusion 2.90 1.24-6.77 3.17 1.29-7.83
Endoscopy 2.80 1.34-5.84 2.06 0.94-4.51
Needle sharing 9.73 0.83-114.09 4.08 0.40-41.23
Adjusted OR 95% CI Adjusted OR 95% CI
Hospital controls Community controls
Risk factors
Table 4. Multivariate analysis of risk factors for hepatitis C virus
genotype 1b
Female 0.26 0.13-0.53 0.29 0.14-0.60
Age (10 yr) 0.85 0.55-1.32 1.33 0.87-2.03
Blood transfusion 2.75 1.28-5.91 4.55 2.00-10.38
Endoscopy 3.57 1.69-7.55 2.16 1.00-4.66
Adjusted OR 95% CI Adjusted OR 95% CI
Hospital controls Community controls
Risk factors
Table 6. Multivariate analysis of risk factors for hepatitis C Virus
genotype 2a
Surgical procedure Yes 32 47.8 62 50.8 1.47 (0.59-2.20) 37 37.0 1.93 (0.98-3.83)
No 35 52.2 60 49.2 63 63.0
Blood transfusion Yes 25 39.7 23 19.8 3.02 (1.55-5.88) 16 16.5 4.85 (2.23-10.54)
No 38 60.3 93 80.2 81 83.5
Needle sharing Yes 3 4.8 2 1.8 2.48 (0.28-21.66) 1 1.1 4.86 (0.33-72.2)
No 59 95.2 110 98.2 88 98.9
Endoscopy Yes 49 70.0 56 46.3 2.87 (1.47-5.60) 61 60.4 2.00 (0.98-4.07)
No 21 30.0 65 53.7 40 39.6
Dental procedure Yes 41 67.2 78 67.2 0.83 (0.42-8.44) 65 68.4 0.82 (0.39-1.70)
No 20 32.8 38 32.8 30 31.6
Acupuncture Yes 53 80.3 95 78.5 1.27 (0.56-2.88) 74 77.1 1.01 (0.45-2.26)
No 13 19.7 26 21.5 22 22.9
Tattooing Yes 11 16.9 20 16.9 1.64 (0.63-4.29) 28 29.2 0.69 (0.29-1.64)
No 54 83.1 98 83.1 68 70.8
Ear piercing Yes 10 15.4 38 31.9 0.79 (0.32-1.98) 38 39.2 0.42 (0.17-1.03)
No 55 84.6 81 68.1 59 60.8
History of hemodialysis Yes 3 10.0 0 0.0 - 0 0.0 -
No 27 90.0 54 100.0 80 100.0
History of STD
# Yes 18 28.6 22 18.6 1.40 (0.69-2.81) 13 13.5 2.07 (0.93-4.63)
No 45 71.4 96 81.4 83 86.5
Family history of hepatitis Yes 20 31.7 59 51.8 0.51 (0.26-0.98) 24 25.8 1.46 (0.72-2.98)
No 43 68.3 55 48.2 69 74.2
Total 68 100.0 125 100.0 101 100.0
No. % No. % No. %
Genotype 2a cases Community controls
OR* (95% CI)
Hospital controls
OR* (95% CI) Characteristics
Table 5. Univariate analysis of potential risk factors for hepatitis C virus genotype 2a
#, Sexually transmitted disease; *, Mantel-Haenszel estimates adjusted for age and sex.Genotypic Risk Factors of HCV Infection 191
Korean patients with HCV infection are 1b and 2a. It also
demonstrates that the risk factors for HCV infection are pre-
vious transfusion, a history of jaundice and endoscopy, which
are not different between genotypes. To our knowledge, this
is the first case-control study to examine the risk factors for
HCV infection according to genotypes in Korea. Our results
thus provide an interesting contrast to investigations of hep-
atitis C in other countries.
By selecting the cases and hospital controls from a group
of health examinees during a defined period, and who were
assigned the same hospital, we designed a hospital-based case-
control study. Although a higher proportion of women and
younger subjects were enrolled in the hospital controls than
were present in the cases, no significant differences exist be-
tween the two groups with respect to demographic and other
general characteristics. We also enrolled the spouses of the
case group as community controls and compared their results
with those of hospital-based controls. Moreover, despite the
higher representation of women in the community controls
than in the cases, no significant differences were found be-
tween the two groups. In addition, the risk factors for HCV
infection, such as past medical history, were not affected by
the spouse. As such, these groups make valid comparisons
with respect to risk factor evaluation. 
In this study, genotype 1b and genotype 2a were the most
frequent genotypes, which is consistent with some studies
in Korea (7) and Europe (8), but not all studies (2, 6). In pa-
tients with liver cirrhosis, genotype 2a was more common
genotype (55.6%) than in those with HCV RNA carrier and
hepatitis (33-40%). Genotypic associations with more severe
forms of liver disease is an issue that deserves separate study.
Several studies have suggested that genotype 1b is associated
with the risk for cirrhosis (8) and the development of hepa-
tocellular carcinoma (9), whilst others found no association
between genotypes and the progression to cirrhosis (10). 
This study showed that transfusion, the classic form of
parenteral transmission, was related significantly to HCV
infection, and this is consistent with other studies (11, 12).
Endoscopy was found to be associated with an increased risk
of HCV infection, again this is consistent with other studies,
which suggested that HCV could be transmitted during en-
doscopic examination (13, 14). The odds ratio of endoscopy
as a risk of HCV infection, as determined by logistic regres-
sion, was significant in the community controls and incon-
sistent in the hospital controls. The difference may be due
to more experience of endoscopy in the hospital controls. Our
previous hospital-based case-control study also showed that
endoscopy was not associated with HCV infection (15). We
did not fully evaluate intravenous drug use (needle sharing) as
a risk factor due to the low prevalence of drug users amongst
the cases and the controls. However, our previous study showed
that needle sharing is not a major risk factor for HCV infec-
tion among Koreans (16). Previous surgery was found not
to be a risk factor for HCV infection in this study, which is
consistent with some (17, 18), but not all studies (3, 19). Even
though the prevalence of acupuncture was high in the study
population, it was not found to be a risk factor for HCV in-
fection. This finding conflicts with the results of another
study in Taiwan (3) that found acupuncture to be a route of
HCV transmission. Other risk factors of parenteral exposure,
such as tattooing, dental procedures and ear piercing, were
not found to be associated with HCV infection, but this is
also controversial (3, 12, 19, 20). 
Some limitations of our study are; first, there may be some
volunteer effect in the selection of cases and controls from the
health examinees (21). Second, our study population was not
large enough to evaluate uncommon risk factors. Even with
these limitations, we are able to conclude that the most fre-
quent genotypes among Korean patients with HCV infection
are 1b and 2a, and that the risk factors for HCV infection are
previous transfusion and endoscopy, none of which showed
genotypic differences. 
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